FUHRMANN ULRIKE
No ORCID on file
· 375 papers in corpus
· active 2006-2011
Frequent coauthors
- SCHMIDT ANJA 360
- MOELLER CARSTEN 360
- SCHWEDE WOLFGANG 225
- SCHMEES NORBERT 135
- KAUFMANN-REICHE ULRIKE 120
- BOTHE ULRICH 120
- ROTGERI ANDREA 105
- KIRKLAND THOMAS ANDREW 90
- HILLISCH ALEXANDER 60
- DROESCHER PETER 60
2011
The invention relates to the treatment of endometriosis using cMet inhibitors, and medication comprising cMet inhibitors for treating endometriosis.
2011
The invention relates to the treatment of endometriosis using cMet inhibitors, and medication comprising cMet inhibitors for treating endometriosis.
2011
The invention relates to the treatment of endometriosis using cMet inhibitors, and medication comprising cMet inhibitors for treating endometriosis.
2011
The invention relates to the treatment of endometriosis using cMet inhibitors, and medication comprising cMet inhibitors for treating endometriosis.
2011
The invention relates to the treatment of endometriosis using cMet inhibitors, and medication comprising cMet inhibitors for treating endometriosis.
2011
The invention relates to the treatment of endometriosis using cMet inhibitors, and medication comprising cMet inhibitors for treating endometriosis.
2011
The invention relates to the treatment of endometriosis using cMet inhibitors, and medication comprising cMet inhibitors for treating endometriosis.
2011
The invention relates to the treatment of endometriosis using cMet inhibitors, and medication comprising cMet inhibitors for treating endometriosis.
2011
The invention relates to the treatment of endometriosis using cMet inhibitors, and medication comprising cMet inhibitors for treating endometriosis.
2011
The invention relates to the treatment of endometriosis using cMet inhibitors, and medication comprising cMet inhibitors for treating endometriosis.
2011
The invention relates to the treatment of endometriosis using cMet inhibitors, and medication comprising cMet inhibitors for treating endometriosis.
2011
The invention relates to the treatment of endometriosis using cMet inhibitors, and medication comprising cMet inhibitors for treating endometriosis.
2011
The invention relates to the treatment of endometriosis using cMet inhibitors, and medication comprising cMet inhibitors for treating endometriosis.
2011
The invention relates to the treatment of endometriosis using cMet inhibitors, and medication comprising cMet inhibitors for treating endometriosis.
2011
The invention relates to the treatment of endometriosis using cMet inhibitors, and medication comprising cMet inhibitors for treating endometriosis.
2011
The present invention provides the use of mineralocorticoid receptor antagonists for preparing a medicament for the treatment of endometriosis. The present invention relates in particular to an improved therapeutic composition for endometri…
2011
The present invention provides the use of mineralocorticoid receptor antagonists for preparing a medicament for the treatment of endometriosis. The present invention relates in particular to an improved therapeutic composition for endometri…
2011
The present invention provides the use of mineralocorticoid receptor antagonists for preparing a medicament for the treatment of endometriosis. The present invention relates in particular to an improved therapeutic composition for endometri…
2011
The present invention provides the use of mineralocorticoid receptor antagonists for preparing a medicament for the treatment of endometriosis. The present invention relates in particular to an improved therapeutic composition for endometri…
2011
The present invention provides the use of mineralocorticoid receptor antagonists for preparing a medicament for the treatment of endometriosis. The present invention relates in particular to an improved therapeutic composition for endometri…
2011
The present invention provides the use of mineralocorticoid receptor antagonists for preparing a medicament for the treatment of endometriosis. The present invention relates in particular to an improved therapeutic composition for endometri…
2011
The present invention provides the use of mineralocorticoid receptor antagonists for preparing a medicament for the treatment of endometriosis. The present invention relates in particular to an improved therapeutic composition for endometri…
2011
The present invention provides the use of mineralocorticoid receptor antagonists for preparing a medicament for the treatment of endometriosis. The present invention relates in particular to an improved therapeutic composition for endometri…
2011
The present invention provides the use of mineralocorticoid receptor antagonists for preparing a medicament for the treatment of endometriosis. The present invention relates in particular to an improved therapeutic composition for endometri…
2011
The present invention provides the use of mineralocorticoid receptor antagonists for preparing a medicament for the treatment of endometriosis. The present invention relates in particular to an improved therapeutic composition for endometri…